ROIV

Roivant Sciences Ltd (ROIV)

US
$ 11.010.09%

Price Chart

Key Statistics

Market Cap
$ 7.91B
P/E Ratio
0.00
Revenue (TTM)
$ 29.05M
Volume
7.95M
52W High
$ 13.05
52W Low
$ 8.73
Dividend Yield
0.00%
Beta
1.16

Technicals

50-Day MA
11.1481
200-Day MA
11.1791
52 Week High
13.055
52 Week Low
8.73

About ROIV

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Employees
750
Headquarters
London, United Kingdom
CEO
Mr. Matthew Gline

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96